J.H. Whitney Equity Partners V Sells 919,389 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $7,355,112.00. Following the sale, the insider directly owned 12,531,158 shares of the company’s stock, valued at $100,249,264. This trade represents a 6.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60.

Aveanna Healthcare Stock Up 1.5%

Shares of NASDAQ AVAH traded up $0.12 during midday trading on Friday, hitting $8.61. 953,109 shares of the company’s stock were exchanged, compared to its average volume of 1,436,922. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.73 and a twelve month high of $10.32. The company has a market cap of $1.87 billion, a PE ratio of 7.29, a P/E/G ratio of 0.87 and a beta of 1.93. The firm’s fifty day simple moving average is $7.10 and its 200-day simple moving average is $7.57.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.91 million during the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.Aveanna Healthcare’s revenue for the quarter was up 15.9% compared to the same quarter last year. Research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on AVAH shares. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Barclays decreased their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research note on Monday, May 18th. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a report on Friday, March 20th. Finally, BMO Capital Markets cut their target price on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.50.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Segall Bryant & Hamill LLC grew its holdings in shares of Aveanna Healthcare by 425.8% during the first quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after buying an additional 132,779 shares during the last quarter. Bank of America Corp DE raised its stake in Aveanna Healthcare by 64.2% during the 1st quarter. Bank of America Corp DE now owns 402,510 shares of the company’s stock valued at $2,592,000 after acquiring an additional 157,368 shares during the last quarter. Smith Group Asset Management LLC lifted its position in Aveanna Healthcare by 34.3% during the 1st quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock worth $1,698,000 after acquiring an additional 67,393 shares during the period. EverSource Wealth Advisors LLC grew its stake in shares of Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock valued at $113,000 after purchasing an additional 3,172 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Aveanna Healthcare by 56.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company’s stock valued at $235,000 after purchasing an additional 13,155 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.